Name

Bortezomib

Alternate Names

LDP-341
MLN-341
PS-341
Velcade

Abbreviations

None

Category

Chemotherapy

Subcategory

Proteasome Inhibitor

NSC Number

681239

Primary Site

Breast
Mantle cell lymphoma
colorectal
leukemia
lung cancer
multiple myeloma

Histology

None

Remarks

November 14, 2014 update: FDA approved to treat multiple myeloma and Mantle cell lymphoma. In clinical trials for breast, colorectal, and lung cancer.

Coding

This drug should be coded
Glossary